Application of proteomics technology for analyzing the interactions between host cells and intracellular infectious agents

Proteomics

Volumn 8, Issue 4, 2008, Pages 852-873

  Coiras, Mayte ^a   Camafeita, Emilio ^b   López Huertas, María Rosa ^a   Calvo, Enrique ^b   López, Juan Antonio ^b   Alcamí, José ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

Author keywords

Biomolecular interaction analysis; Host pathogen interaction; Interaction profiling; Protein differential expression; Proteomics methods

Indexed keywords

APOPTOSIS; CELL FRACTIONATION; CELL FUNCTION; CYTOSKELETON; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOST CELL; HOST PATHOGEN INTERACTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOPRECIPITATION; IMMUNOSURVEILLANCE; MAJOR HISTOCOMPATIBILITY COMPLEX; MASS SPECTROMETRY; NONHUMAN; PATHOGENESIS; PATHOGENICITY; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN MODIFICATION; PROTEOMICS; REVIEW; SEVERE ACUTE RESPIRATORY SYNDROME; TWO DIMENSIONAL GEL ELECTROPHORESIS; VIRULENCE;

ANIMALS; APOPTOSIS; CELL FRACTIONATION; CYTOSKELETON; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY; INFECTION; ISOTOPE LABELING; PROTEIN INTERACTION MAPPING; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEINS; PROTEOMICS; SIGNAL TRANSDUCTION; VIRULENCE;

EID: 40549135956     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200700664     Document Type: Review

References (205)

1. Nathanson, N., Gonzalez-Scarano, F., in: Nathanson, N. (Ed.), Viral pathogenesis and immunity, Academic Press, San Diego 2007, pp. 113-129.
2. Stevenson, M., HIV-1 pathogenesis. Nat. Med. 2003, 9, 853-860.
3. Greene, W. C., Peterlin, B. M., Charting HIV's remarkable voyage through the cell: Basic science as a passport to future therapy. Nat. Med. 2002, 8, 673-680.
4. Hardwick, J. M., Griffin, D. E., in: Nathanson, N. (Ed.), Viral pathogenesis, Lippincott-Raven, Philadelphia 1997, pp. 55-84.
5. Schneider, R. J., Shenk, T., Impact of virus infection on host cell protein synthesis. Annu. Rev. Biochem. 1987, 56, 317-332.
6. Alonso, C. (Ed.), Progress in Molecular and Subcellular Biology Series, Springer-Verlag, Berlin 2004, pp. 207-243.
7. Bachelerie, F., Alcami, J., Arenzana-Seisdedos, F., Virelizier, J. L., HIV enhancer activity perpetuated by NF-kappa B induction on infection of monocytes. Nature 1991, 350, 709-712.
8. Baumann, J. G., Intracellular restriction factors in mammalian cells - An ancient defense system finds a modern foe. Curr. HIV Res. 2006, 4, 141-168.
9. Garcia, M. A., Meurs, E. F., Esteban, M., The dsRNA protein kinase PKR: Virus and cell control. Biochimie 2007, (in press).
10. Nisole, S., Stoye, J. P., Saib, A., TRIM family proteins: retroviral restriction and antiviral defence. Nat. Rev. Microbiol. 2005, 3, 799-808.
11. Chiu, Y. L., Greene, W. C., APOBEC3 cytidine deaminases: distinct antiviral actions along the retroviral life cycle. J. Biol. Chem. 2006, 281, 8309-8312.
12. Alcami, A., Viral mimicry of cytokines, chemokines and their receptors. Nat. Rev. Immunol. 2003, 3, 36-50.
13. Guma, M., Angulo, A., Lopez-Botet, M., NK cell receptors involved in the response to human cytomegalovirus infection. Curr. Top. Microbiol. Immunol. 2006, 298, 207-223.
14. Margulies, D. H., McCluskey, J., in: Paul, W. E. (Ed.), The Major Histocompatibility Complex and Its Encoded Proteins, Lippincott Williams and Wilkins, Philadelphia 2003, pp. 571-612.
15. Alcami, A., Koszinowski, U. H., Viral mechanisms of immune evasion. Trends Microbiol. 2000, 8, 410-418.
16. Hilleman, M. R., Strategies and mechanisms for host and pathogen survival in acute and persistent viral infections. Proc. Natl. Acad. Sci. USA 2004, 101, Suppl 2, 14560-14566.
17. Doytchinova, I. A., Taylor, P., Flower, D. R., Proteomics in vaccinology and immunobiology: An informatics perspective of the immunone. J. Biomed. Biotechnol. 2003, 5, 267-290.
18. Walduck, A., Rudel, T., Meyer, T. F., Proteomic and gene profiling approaches to study host responses to bacterial infection. Curr. Opin. Microbiol. 2004, 7, 33-38.
19. O'Farrell, P. H., High resolution two-dimensional electrophoresis of proteins. J. Biol. Chem. 1975, 250, 4007-4021.
20. Fenn, J. B., Mann, M., Meng, C. K., Wong, S. F., Whitehouse C. M., Electrospray ionization for mass spectrometry of large biomolecules. Science 1989, 246, 64-71.
21. Karas, M., Hillenkamp, F., Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. Anal. Chem. 1988, 60, 2299-2301.
22. Herbert, B., Advances in protein solubilisation for two-dimensional electrophoresis. Electrophoresis 1999, 20, 660-663.
23. Görg, A., Weiss, W., Dunn, M. J., Current two-dimensional electrophoresis technology for proteomics. Proteomics 2004, 4, 3665-3685.
24. Zhang, C. G., Chromy, B. A., McCutchen-Maloney, S. L., Host-pathogen interactions: a proteomic view. Expert Rev. Proteomics 2005, 2, 187-202.
25. Josic, D., Clifton, J. G., Use of monolithic supports in proteomics technology. J. Chromatogr. A. 2007, 1144, 2-13.
26. Righetti, P. G., Castagna, A., Antonioli, P., Boschetti, E., Pre-fractionation techniques in proteome analysis: the mining tools of the third millennium. Electrophoresis 2005, 26, 297-319.
27. Molloy, M. P., Two-dimensional electrophoresis of membrane proteins using immobilized pH gradients. Anal. Biochem. 2000, 280, 1-10.
28. Henzel, W. J., Billeci, T. M., Stults, J. T., Wong, S. C. et al., Identifying proteins from two-dimensional gels by molecular mass searching of peptide fragments in protein sequence databases.Proc. Natl. Acad. Sci. USA 1993, 90, 5011-5015.
29. Hunt, D. F., Yates, J. R. III, Shabanowitz, J., Winston, S. et al., Protein sequencing by tandem mass spectrometry. Proc. Natl. Acad. Sci. USA 1986, 83, 6233-6237.
30. Jennings, K. R., Collision-induced decompositions of aromatic molecular ions. Int. J. Mass Spectrom. Ion Phys. 1968, 1, 227-235.
31. Aebersold, R., Mann, M., Mass spectrometry-based proteomics. Nature 2003, 422, 198-207.
32. Washburn, M. P., Wolters, D., Yates, J. R. III, Large-scale analysis of the yeast proteome by multidimensional protein identification technology. Nat. Biotechnol. 2001, 19, 242-247.
33. Sam-Yellowe, T. Y., Florens, L., Wang, T., Raine, J. D. et al., Proteome analysis of rhoptry-enriched fractions isolated from Plasmodium merozoites. J. Proteome Res. 2004, 3, 995-1001.
34. Skipp, P., Robinson, J., O'Connor, C. D., Clarke, I. N., Shotgun proteomic analysis of Chlamydia trachomatis. Proteomics 2005, 5, 1558-1573.
35. Vitali, B., Wasinger, V., Brigidi, P., Guilhaus, M., A proteomic view of Bifidobacterium infantis generated by multi-dimensional chromatography coupled with tandem mass spectrometry. Proteomics 2005, 5, 1859-1867.
36. Beyer, A., Bandyopadhyay, S., Ideker, T., Integrating physical and genetic maps: from genomes to interaction networks. Nat. Rev. Genet. 2007, 8, 699-710.
37. Mawuenyega, K. G., Forst, C. V., Dobos, K. M., Belisle, J. T. et al., Mycobacterium tuberculosis functional network analysis by global subcellular protein profiling. Mol. Biol. Cell 2005, 16, 396-404.
38. Graumann, J., Dunipace, L. A., Seol, J. H., McDonald, W. H. et al., Applicability of tandem affinity purification MudPIT to pathway proteomics in yeast. Mol. Cell. Proteomics 2004, 3, 226-237.
39. Unlu, M., Morgan, M. E, Minden, J. S., Difference gel electrophoresis: a single gel method for detecting changes in protein extracts. Electrophoresis 1997, 18, 2071-2077.
40. Gygi, S. P., Rist, B., Gerber, S. A, Turecek, F. et al., Quantitative analysis of complex protein mixtures using isotope-coded affinity tags. Nat. Biotechnol. 1999, 17, 994-999.
41. Ross, P. L., Huang, Y. N., Marchese, J. N., Williamson, B. et al., Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell. Proteomics 2004, 3, 1154-1169.
42. Ong, S. E., Blagoev, B., Kratchmarova, I., Kristensen, D. B. et al., Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell. Proteomics 2002, 1, 376-386.
43. Chertova, E., Chertov, O., Coren, L. V., Roser, J. D. et al., Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages. J. Virol. 2006, 80, 9039-9052.
44. Jahnukainen, T., Malehorn, D., Sun, M., Lyons-Weiler, J. et al., Proteomic analysis of urine in kidney transplant patients with BK virus nephropathy. J. Am. Soc. Nephrol. 2006, 17, 3248-3256.
45. Ravichandran, V., Major, E. O., Viral proteomics: a promising approach for understanding JC virus tropism. Proteomics 2006, 6, 5628-5636.
46. Li, Z., Lin, Q., Chen, J., Wu, J. L. et al., Shotgun identification of structural proteome of shrimp white spot syndrome virus and iTRAQ differentiation of envelope and nucleocapsid subproteomes. Mol. Cell. Proteomics 2007, (in press)
47. Nanamiya, H., Kawamura, F., Kosono, S., Proteomic study of the Bacillus subtilis ribosome: Finding of zinc-dependent replacement for ribosomal protein L31 paralogues. Gen. Appl. Microbiol. 2006, 52, 249-258.
48. Barrios-Llerena, M. E., Reardon, K. F., Wright, P. C., 2-DE proteomic analysis of the model cyanobacterium Anabaena variabilis. Electrophoresis 2007, 28, 1624-1632.
49. Bohmer, M., Colby, T., Bohmer, C., Brautigam, A. et al., Proteomic analysis of dimorphic transition in the phytopathogenic fungus Ustilago maydis. Proteomics 2007, 7, 675-685.
50. Park, K. H., Lipuma, J. J., Lubman, D. M., Comparative proteomic analysis of B. cenocepacia using two-dimensional liquid separations coupled with mass spectrometry. Anal. Chim. Acta 2007, 592, 91-100.
51. Grayston, J. T., Wang, S., New knowledge of chlamydiae and the diseases they cause. J. Infect. Dis. 1975, 132, 87-105.
52. Grayston, J. T., Chlamydia pneumoniae, strain TWAR pneumonia. Annu. Rev. Med. 1992, 43, 317-323.
53. Vandahl, B. B., Birkelund, S., Christiansen, G., Genome and proteome analysis of Chlamydia. Proteomics 2004, 4, 2831-2842.
54. Miyairi, I., Byrne, G. I., Chlamydia and programmed cell death. Curr. Opin. Microbiol. 2006, 9, 102-108.
55. Fischer, S. F., Schwarz, C., Vier, J., Hacker, G., Characterization of antiapoptotic activities of Chlamydia pneumoniae in human cells. Infect. Immun. 2001, 69, 7121-7129.
56. Fischer, S. F., Vier, J., Kirschnek, S., Klos, A. et al., Chlamydia inhibit host cell apoptosis by degradation of proapoptotic BH3-only proteins. J. Exp. Med. 2004, 200, 905-916.
57. Dean, D., Powers, V. C., Persistent Chlamydia trachomatis infections resist apoptotic stimuli.Infect. Immun, 2001, 69, 2442-2447.
58. Beck, S. C., Meyer, T. F., IgA1 protease from Neisseria gonorrhoeae inhibits TNFalpha-mediated apoptosis of human monocytic cells. FEBS Lett. 2000, 472, 287-292.
59. Wallach, D., Cell death induction by TNF: a matter of self control. Trends Biochem. Sci. 1997, 22, 107-109.
60. Angot, A., Vergunst, A., Genin, S., Peeters, N., Exploitation of eukaryotic ubiquitin signaling pathways by effectors translocated by bacterial type III and type IV secretion systems. PLoS Pathog. 2007, 3, e3.
61. Carter, R. S., Pennington, K. N., Ungurait, B. J., Arrate, P., Ballard, D. W., Signal-induced ubiquitination of I kappaB Kinase-beta. J. Biol. Chem. 2003, 278, 48903-48906.
62. Thiefes, A., Wolf, A., Doerrie, A., Grassl, G. A. et al., The Yersinia enterocolitica effector YopP inhibits host cell signalling by inactivating the protein kinase TAK1 in the IL-1 signalling pathway. EMBO Rep. 2006, 7, 838-844.
63. Zhou, H., Monack, D. M., Kayagaki, N., Wertz, I. et al., Yersinia virulence factor YopJ acts as a deubiquitinase to inhibit NF-kappa B activation. J. Exp. Med. 2005, 202, 1327-1732.
64. Grinberg, L. M., Abramova, F.A., Yampolskaya, O. V., Walker, D. H. et al., Quantitative pathology of inhalational anthrax I: quantitative microscopic findings. Mod. Pathol. 2001, 14, 482-495.
65. Hanna, P. C., Acosta, D., Collier, R. J., On the role of macrophages in anthrax. Proc. Natl. Acad. Sci. USA. 1993, 90, 10198-10201.
66. Seo, G. M., Kim, S. J., Kim, J. C., Nam, D. H. et al., Targeting of Bacillus anthracis interaction factors for human macrophages using two-dimensional gel electrophoresis. Biochem. Biophys. Res. Commun. 2004, 322, 854-859.
67. Sapra, R., Gaucher, S. P., Lachmann, J. S., Buffleben, G. M. et al., Proteomic analyses of murine macrophages treated with Bacillus anthracis lethal toxin. Microb. Pathog. 2006, 41, 157-167.
68. Kuhn, J. F., Hoerth, P., Hoehn, S. T., Preckel, T., Tomer, K. B., Proteomics study of anthrax lethal toxin-treated murine macrophages. Electrophoresis 2006, 7, 1584-1597.
69. Hakem, R., Hakem, A., Duncan, G. S., Henderson, J. T. et al., Differential requirement for caspase 9 in apoptotic pathways in vivo. Cell 1998, 94, 339-352.
70. Lai, C. C., Jou, M. J., Huang, S. Y., Li, S. W. et al., Proteomic analysis of up-regulated proteins in human promonocyte cells expressing severe acute respiratory syndrome coronavirus 3C-like protease. Proteomics 2007, 7, 1446-1460.
71. Lin, C. W., Lin, K. H., Hsieh, T. H., Shiu, S. Y., Li, J. Y., Severe acute respiratory syndrome Coronavirus 3C-like protease-induced apoptosis. FEMS Immunol. Med. Microbiol. 2006, 46, 375-380.
72. Roos-Mattjus, P., Sistonen, L., The ubiquitin-proteasome pathway. Ann. Med. 2004, 36, 285-295.
73. Shinomiya, H., Nagai, K., Hirata, H., Kobayashi, N. et al., Preparation and characterization of recombinant murine p65/L-plastin expressed in Escherichia coli and high-titer antibodies against the protein. Biosci. Biotechnol. Biochem. 2003, 67, 1368-1375.
74. Gruenheid, S., Finlay, B. B., Microbial pathogenesis and cytoskeletal function. Nature 2003, 422, 775-781.
75. Backen, S., Schwarz, T., Miehlke, S., Kirsch, C. et al., Functional analysis of the cag pathogenicity island in Helicobacter pylori isolates from patients with gastritis, peptic ulcer, and gastric cancer. Infect. Immun. 2004, 72, 1043-1056.
76. Fischer, R. S., Fritz-Six, K. L., Fowler, V. M., Pointed-end capping by tropomodulin3 negatively regulates endothelial cell motility. J. Cell Biol. 2003, 161, 371-380.
77. Melendez, J., Welch, S., Schaefer, E., Moravec, C. S., Activation of pyk2/related focal adhesion tyrosine kinase and focal adhesion kinase in cardiac remodeling. J. Biol. Chem. 2002, 277, 45203-45210.
78. Selbach, M., Moese, S., Hurwitz, R., Hauck, C. R. et al., The Helicobacter pylori CagA protein induces cortactin dephosphorylation and actin rearrangement by c-Src inactivation. EMBO J. 2003, 22, 515-528.
79. Moese, S., Selbach, M., Kwok, T., Brinkmann, V. et al., Helicobacter pylori induces AGS cell motility and elongation via independent signaling pathways. Infect. Immun. 2004, 72, 3646-3649.
80. Backert, S., Gressmann, H., Kwok, T., Zimny-Arndt, U. et al., Gene expression and protein profiling of AGS gastric epithelial cells upon infection with Helicobacter pylori. Proteomics 2005, 5, 3902-3918.
81. Kahn, R. A., Fu, H., Roy, C. R., Cellular hijacking: a common strategy for microbial infection. Trends Biochem. Sci. 2002, 27, 308-314.
82. Robbins, J. R., Barth, A. I., Marquis, H., de Hostos, E.L. et al., Listeria monocytogenes exploits normal host cell processes to spread from cell to cell. J. Cell. Biol. 1999, 146, 1333-1350.
83. Kocks, C., Gouin, E., Tabouret, M., Berche, P. et al., L. monocytogenes-induced actin assembly requires the actA gene product, a surface protein. Cell 1992, 68, 521-531.
84. Chen, H., Bernstein, B. W., Bamburg, J. R., Regulating actin-filament dynamics in vivo. Trends Biochem. Sci. 2000, 25, 19-23.
85. Leong, W. F., Chow, V. T., Transcriptomic and proteomic analyses of rhabdomyosarcoma cells reveal differential cellular gene expression in response to enterovirus 71 infection. Cell Microbiol. 2006, 8, 565-580.
86. Gavet, O., Ozon, S., Manceau, V., Lawler, S. et al., The stathmin phosphoprotein family: intracellular localization and effects on the microtubule network. J. Cell Sci. 1998, 111, 3333-3346.
87. Cheon, M. S., Bajo, M., Gulesserian, T., Cairns, N., Lubec, G., Evidence for the relation of herpes simplex virus type 1 to Down syndrome and Alzheimer's disease. Electrophoresis 2001, 22, 445-448.
88. Badorff, C., Lee, G. H., Lamphear, B. J., Martone, M. E., et al., Enteroviral protease 2A cleaves dystrophin: evidence of cytoskeletal disruption in an acquired cardiomyopathy. Nat. Med. 1999, 5, 320-326.
89. Rassmann, A., Henke, A., Zobawa, M., Carlsohn, M. et al., Proteome alterations in human host cells infected with coxsackievirus B3. J. Gen. Virol. 2006, 87, 2631-2638.
90. Burke, B., Stewart, C. L., Life at the edge: the nuclear envelope and human disease. Nat. Rev. Mol. Cell Biol. 2002, 3, 575-585.
91. Neuveut, C., Jeang, K. T., Recombinant human immunodeficiency virus type 1 genomes with tat unconstrained by overlapping reading frames reveal residues in Tat important for replication in tissue culture. J. Virol. 1996, 70, 5572-5581.
92. Coiras, M., Camafeita, E., Urena, T., Lopez, J. A. et al., Modifications in the human T cell proteome induced by intracellular HIV-1 Tat protein expression. Proteomics 2006, 6, S63-3.
93. Chen, D., Wang, M., Zhou, S., Zhou, Q., HIV-1 Tat targets microtubules to induce apoptosis, a process promoted by the pro-apoptotic Bcl-2 relative Bim. EMBO J. 2002, 21, 6801-6810.
94. Dubey, J. P., Persistence of Toxoplasma gondii in the tissues of chronically infected cats. J. Parasitol. 1977, 63, 156-157.
95. Dubremetz, J. F., Garcia-Reguet, N., Conseil, V., Fourmaux, M. N., Apical organelles and host-cell invasion by Apicomplexa. Int. J. Parasitol. 1998, 28, 1007-1013.
96. Carruthers, V. B., Armed and dangerous: Toxoplasma gondii uses an arsenal of secretory proteins to infect host cells. Parasitol. Int. 1999, 48, 1-10.
97. Opitz, C., Soldati, D., 'The glideosome': a dynamic complex powering gliding motion and host cell invasion by Toxoplasma gondii. Mol. Microbiol. 2002, 45, 597-604.
98. Bradley, P. J., Ward, C., Cheng, S. J., Alexander, D. L. et al., Proteomic analysis of rhoptry organelles reveals many novel constituents for host-parasite interactions in Toxoplasma gondii. J. Biol. Chem. 2005, 280, 34245-34258.
99. Cornell, C. T., Kiosses, W. B., Harkins, S., Whitton, J. L., Coxsackievirus b3 proteins directionally complement each other to downregulate surface major histocompatibility complex class I. J. Virol. 2007, 81, 6785-6797.
100. Deitz, S. B., Dodd, D. A., Cooper, S., Parham, P., Kirkegaard, K., MHC I-dependent antigen presentation is inhibited by poliovirus protein 3A. Proc. Natl. Acad. Sci. USA 2000, 97, 13790-13795.
101. Dodd, D. A., Giddings, T. H. Jr, Kirkegaard, K., Poliovirus 3A protein limits interleukin-6 (IL-6), IL-8, and beta interferon secretion during viral infection. J. Virol. 2001, 75, 8158-8165.
102. Piguet, V., Wan, L., Borel, C., Mangasarian, A. et al., HIV-1 Nef protein binds to the cellular protein PACS-1 to down-regulate class I major histocompatibility complexes. Nat. Cell Biol. 2000, 2, 163-197.
103. Schwartz, O., Maréchal, V., Le Gall, S., Lemonnier, F., Heard, J. M., Endocytosis of major histocompatibility complex class I molecules is induced by the HIV-1 Nef protein. Nature Med. 1996, 2, 338-342.
104. Wan, L., Molloy, S. S., Thomas, L., Liu, G. et al., PACS-1 defines a novel gene family of cytosolic sorting proteins required for trans-Golgi network localization. Cell 1998, 94, 205-216.
105. Blagoveshchenskaya, A. D., Thomas, L., Feliciangeli, S. F., Hung, C. H., Thomas, G., HIV-1 Nef downregulates MHC-I by a PACS-1- and PI3K-regulated ARF6 endocytic pathway. Cell 2002, 111, 853-866.
106. Briand, G., Barbeau, B., Tremblay, M., Binding of HIV-1 to its receptor induces tyrosine phosphorylation of several CD4-associated proteins, including the phosphatidylinositol 3-kinase. Virology 1997, 228, 171-179.
107. Schmid-Antomarchi, H., Benkirane, M., Breittmayer, V., Husson, H. et al., HIV induces activation of phosphatidylinositol 4-kinase and mitogen-activated protein kinase by interacting with T cell CD4 surface molecules. Eur. J. Immunol. 1996, 26, 717-720.
108. Tremblay, M., Meloche, S., Gratton, S., Wainberg, M. A., Sekaly, R. P., Association of p56lck with the cytoplasmic domain of CD4 modulates HIV-1 expression. EMBO J. 1994, 13, 774-783.
109. Berube, P., Barbeau, B., Cantin, R., Sekaly, R. P., Tremblay, M., Repression of human immunodeficiency virus type 1 long terminal repeat-driven gene expression by binding of the virus to its primary cellular receptor, the CD4 molecule. J. Virol. 1996, 70, 4009-4016.
110. Tremblay, M. J., Fortin, J. F., Cantin, R., The acquisition of host-encoded proteins by nascent HIV-1. Immunol. Today 1998, 19, 346-351.
111. Mannova, P., Fang, R., Wang, H., Deng, B. et al., Modification of host lipid raft proteome upon hepatitis C virus replication. Mol. Cell. Proteomics 2006, 5, 2319-2325.
112. Pfeffer, S., Aivazian, D., Targeting Rab GTPases to distinct membrane compartments. Nat. Rev Mol. Cell. Biol. 2004, 5, 886-889.
113. Schwartz, M., Rho signalling at a glance. J. Cell. Sci. 2004, 117, 5457-5458.
114. Mannová, P., Beretta, L., Activation of the N-Ras-PI3K-Akt-mTOR pathway by hepatitis C virus: control of cell survival and viral replication. J. Virol. 2005, 79, 8742-8749.
115. Marques, M. A., Espinosa, B. J., Xavier da Silveira, E. K., Pessolani, M. C. et al., Continued proteomic analysis of Mycobacterium leprae subcellular fractions. Proteomics 2004, 4, 2942-2953.
116. Bloom, B.R. (Ed.), in: Tuberculosis: Pathogenesis, Protection and Control. American Society for Microbiology Press, Washington 1994, pp. 353-385.
117. Ray, R. B., Ray, R.Hepatitis C virus core protein: intriguing properties and functional relevance. FEMS Microbiol. Lett. 2001, 202, 149-156.
118. Sato, S., Fukasawa, M., Yamakawa, Y., Natsume, T. et al., Proteomic profiling of lipid droplet proteins in hepatoma cell lines expressing hepatitis C virus core protein. J. Biochem. 2006, 139, 921-930.
119. Bai, G., Shaner, G., Management and resistance in wheat and barley to Fusarium head blight. Annu. Rev. Phytopathol. 2004, 42, 135-161.
120. Buerstmayr, H., Lemmens, M., Hartl, L., Doldi, L. et al., Molecular mapping of QTLs for Fusarium head blight resistance in spring wheat. I. Resistance to fungal spread (Type II resistance). Theor. Appl. Genet. 2002, 104, 84-91.
121. Zhou, W., Eudes, F., Laroche, A., Identification of differentially regulated proteins in response to a compatible interaction between the pathogen Fusarium graminearum and its host, Triticum aestivum. Proteomics 2006, 6, 4599-4609.
122. Mayer, D., Molawi, K., Martínez-Sobrido, L., Ghanem, A. et al., Identification of cellular interaction partners of the influenza virus ribonucleoprotein complex and polymerase complex using proteomic-based approaches. J. Proteome Res. 2007, 6, 672-682.
123. Wang, P., Palese, P., O'Neil, R. E., The NPI-1/NPI-3 (karyopherin alpha) binding site on the influenza a virus nucleoprotein NP is a nonconventional nuclear localization signal. J. Virol. 1997, 71, 1850-1856.
124. Digard, P., Elton, D., Bishop, K., Medcalf, E., et al., Modulation of nuclear localization of the influenza virus nucleoprotein through interaction with actin filaments. J. Virol. 1999, 73, 2222-2231.
125. Huarte, M., Sanz-Ezquerro, J. J., Roncal, F., Ortin, J., Nieto, A., PA subunit from influenza virus polymerase complex interacts with a cellular protein with homology to a family of transcriptional activators. J. Virol. 2001, 75, 8597-8604.
126. Momose, F., Naito, T., Yano, K., Sugimoto, S. et al., Identification of Hsp90 as a stimulatory host factor involved in influenza virus RNA synthesis. J. Biol. Chem. 2002, 277, 45306-45314.
127. Engelhardt, O. G., Smith, M., Fodor, E., Association of the influenza A virus RNA-dependent RNA polymerase with cellular RNA polymerase II. J. Virol. 2005, 79, 5812-5818.
128. Taylor, T. J., Knipe, D. M., Proteomics of herpes simplex virus replication compartments: association of cellular DNA replication, repair, recombination, and chromatin remodeling proteins with ICP8. J. Virol. 2004, 78, 5856-5866.
129. Shi, L., Adkins, J. N., Coleman, J. R., Schepmoes, A. A. et al., Proteomic analysis of Salmonella enterica serovar typhimurium isolated from RAW 264.7 macrophages: identification of a novel protein that contributes to the replication of serovar typhimurium inside macrophages. J. Biol. Chem. 2006, 281, 29131-29140.
130. Boneca, I. G., The role of peptidoglycan in pathogenesis. Curr. Opin. Microbiol. 2005, 8, 46-53.
131. Tuomanen, E., Molecular and cellular biology of pneumococcal infection. Curr. Opin. Microbiol. 1999, 2, 35-39.
132. Charpentier, E., Novak, R., Tuomanen, E., Regulation of growth inhibition at high temperature, autolysis, transformation and adherence in Streptococcus pneumoniae by clpC. Mol. Microbiol. 2000, 37, 717-726.
133. Bae, S. M., Yeon, S. M., Kim, T. S., Lee, K. J., The effect of protein expression of Streptococcus pneumoniae by blood. J. Biochem. Mol. Biol. 2006, 39, 703-708.
134. Lee, K. J., Bae, S. M., Lee, M. R., Yeon, S. M. et al., Proteomic analysis of growth phase-dependent proteins of Streptococcus pneumoniae. Proteomics 2006, 6, 1274-1282.
135. Lee, M. R., Bae, S. M., Kim, T. S., Lee, K. J., Proteomic analysis of protein expression in Streptococcus pneumoniae in response to temperature shift. J. Microbiol. 2006, 44, 375-382.
136. Pawson, T., Scott, J. D., Signaling through scaffold, anchoring, and adaptor proteins. Science 1997, 278, 2075-2080.
137. Gronborg, M., Kristiansen, T. Z., Stensballe, A., Andersen, J. S., et al., A mass spectrometry-based proteomic approach for identification of serine/threonine-phosphorylated proteins by enrichment with phospho-specific antibodies: identification of a novel protein, Frigg, as a protein kinase A substrate. Mol. Cell. Proteomics 2002, 1, 517-527.
138. Ficarro, S. B., McCleland, M. L., Stukenberg, P. T., Burke, D. J. et al., Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae. Nat. Biotechnol. 2002, 20, 301-305.
139. Law, L. M. J., Everitt, J. C., Beatch, M. D., Holmes, C. F. B., Hobman, T. C., Phosphorylation of rubella virus capsid regulates its RNA binding activity and virus replication. J. Virol. 2003, 77, 1764-1771.
140. Neumann, G., Castrucci, M. R., Kawaoka, Y., Nuclear import and export of influenza virus nucleoprotein. J. Virol. 1997, 71, 9690-9700.
141. Wu, X., Gong, X., Foley, H. D., Schnell, M. J., Fu, Z. F., Both viral transcription and replication are reduced when the rabies virus nucleoprotein is not phosphorylated. J. Virol. 2002, 76, 4153-4161.
142. Chalmers, M. J., Kolch, W., Emmett, M. R., Marshall, A. G., Mischak, H., Identification and analysis of phosphopeptides. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2004, 803, 111-120.
143. Calvo, E., Escors, D., López, J. A., González, J. M. et al., Phosphorylation and subcellular localization of transmissible gastroenteritis virus nucleocapsid protein in infected cells. J. Gen. Virol. 2005, 86, 2255-2267.
144. Laude, H., Masters, P. S., in: Siddell, S.G. (Ed.), The Coronavirus Nucleocapsid Protein, Plenum Press, New York 1995, pp. 141-163.
145. Asenjo, A., Calvo, E., Villanueva, N., Phosphorylation of human respiratory syncytial virus P protein at threonine 108 controls its interaction with the M2-1 protein in the viral RNA polymerase complex. J. Gen. Virol. 2006, 87, 3637-3642.
146. Pitarch, A., Sánchez, M., Nombela, C., Gil, C., Sequential fractionation and two-dimensional gel analysis unravels the complexity of the dimorphic fungus Candida albicans cell wall proteome. Mol. Cell. Proteomics 2002, 1, 967-982.
147. Hubalek, M., Hernychova, L., Brychta, M., Lenco, J. et al., Comparative proteome analysis of cellular proteins extracted from highly virulent Francisella tularensis ssp. tularensis and less virulent F. tularensis ssp. holarctica and F. tularensis ssp. Mediaasiatica. Proteomics 2004, 4, 3048-3060.
148. Lenco, J., Hubalek, M., Larsson, P., Fucikova, A. et al., Proteomics analysis of the Francisella tularensis LVS response to iron restriction: induction of the F. tularensis pathogenicity island proteins IgIABC. FEMS Microbiol. Lett. 2007, 269, 11-21.
149. Jia, J., Wang, Y., Zhou, L., Jin, S., Expression of Pseudomonas aeruginosa toxin ExoS effectively induces apoptosis in host cells. Infect. Immun. 2006, 74, 6557-6570.
150. Chromy, B. A., Choi, M. W., Murphy, G. A., Gonzales, A. D. et al., Proteomic characterization of Yersinia pestis virulence. J. Bacteriol. 2005, 187, 8172-8180.
151. Calvo, E., Pucciarelli, M. G., Bierne, H., Cossart, P. et al., Analysis of the Listeria cell wall proteome by two-dimensional nanoliquid chromatography coupled to mass spectrometry. Proteomics 2005, 5, 433-443.
152. Manchee, R. J., Bacillus anthracis on Gruinard Island. Nature 1981, 294, 254-255.
153. Redmond, C., Baillie, L. W., Hibbs, S., Moir, A. J. et al., Identification of proteins in the exosporium of Bacillus anthracis. Microbiology, 2004, 150, 355-363.
154. Huang, C. M., Foster, K. W., DeSilva, T. S., Van Kampen, K. R. et al., Identification of Bacillus anthracis proteins associated with germination and early outgrowth by proteomic profiling of anthrax spores. Proteomics 2004, 4, 2653-2661.
155. Chitlaru, T., Gat, O., Gozlan, Y., Ariel, N. et al., Differential proteomic analysis of the Bacillus anthracis secretome: distinct plasmid and chromosome CO2-dependent cross talk mechanisms modulate extracellular proteolytic activities. J. Bacteriol. 2006, 188, 3551-3571.
156. Manabe, Y. C., Bishai, W. R., Latent Mycobacterium tuberculosis-persistence, patience, and winning by waiting. Nat. Med. 2000, 6, 1327-1329.
157. Starck, J., Källenius, G., Marklund, B. I., Andersson, D. I., Akerlund, T.Comparative proteome analysis of Mycobacterium tuberculosis grown under aerobic and anaerobic conditions. Microbiology 2004, 150, 3821-3829.
158. Sinha, S., Kosalai, K., Arora, S., Namane, A. et al., Immunogenic membrane-associated proteins of Mycobacterium tuberculosis revealed by proteomics. Microbiology 2005, 151, 2411-2419.
159. Mattow, J., Siejak, F., Hagens, K., Becher, D. et al., Proteins unique to intraphagosomally grown Mycobacterium tuberculosis. Proteomics, 2006, 6, 2485-2494.
160. Theg, D. E., Becker, C., Beard, J. W., Virus of avian myeloblastosis (Bai strain A). XXV. Ultracytochemical study of virus and myeloblast phosphatase activity J. Natl. Cancer Inst. 1964, 32, 201-235.
161. Aoki, T., Boyse, E. A., Old, L. J., De Harven, E. et al., G (Gross) and H-2 cell-surface antigens: location on Gross leukemia cells by electron microscopy with visually labeled antibody. Proc. Natl. Acad. Sci. USA 1970, 65, 569-576.
162. Bubbers, J. E., Lilly, F., Selective incorporation of H-2 antigenic determinants into Friend virus particles. Nature 1977, 266, 458-459.
163. Azocar, J., Essex, M., Incorporation of HLA antigens into the envelope of RNA tumor viruses grown in human cells. Cancer Res. 1979, 39, 3388-3391.
164. Tan, K.B., Histones: metabolism in simian virus 40-infected cells and incorporation into virions. Proc. Natl. Acad. Sci. USA 1977, 74, 2805-2809.
165. Calafat, J., Janssen, H., Démant, P., Hilgers, J., Závada, J., Specific selection of host cell glycoproteins during assembly of murine leukaemia virus and vesicular stomatitis virus: presence of Thy-1 glycoprotein and absence of H-2, Pgp-1 and T-200 glycoproteins on the envelopes of these virus particles. J. Gen. Virol. 1983, 64, 1241-1253.
166. Lando, Z., Sarin, P., Megson, M., Greene, W.C. et al., Association of human T-cell leukaemia/lymphoma virus with the Tac antigen marker for the human T-cell growth factor receptor. Nature 1983, 305, 733-736.
167. Spear, G. T., Lurain, N. S., Parker, C. J., Ghassemi, M. et al., Host cell-derived complement control proteins CD55 and CD59 are incorporated into the virions of two unrelated enveloped viruses. Human T cell leukemia/lymphoma virus type I (HTLV-I) and human cytomegalovirus (HCMV). J. Immunol. 1995, 155, 4376-4381.
168. Young, J. A., Bates, P., Willert, K., Varmus, H. E., Efficient incorporation of human CD4 protein into avian leukosis virus particles. Science 1990, 250, 1421-1423.
169. Knox, P. G., Young, L. S., Epstein-Barr virus infection of CR2-transfected epithelial cells reveals the presence of MHC class II on the virion. Virology 1995, 213, 147-157.
170. Wright, J. F., Kurosky, A., Pryzdial, E. L., Wasi, S., Host cellular annexin II is associated with cytomegalovirus particles isolated from cultured human fibroblasts. J. Virol. 1995, 69, 4784-4791.
171. Michelson, S., Turowski, P., Picard, L., Goris, J. et al., Human cytomegalovirus carries serine/threonine protein phosphatases PP1 and a host-cell derived PP2A. J. Virol. 1996, 70, 1415-1423.
172. Henderson, L. E., Sowder, R., Copeland, T. D., Oroszlan, S. et al., Direct identification of class II histocompatibility DR proteins in preparations of human T-cell lymphotropic virus type III. J. Virol. 1987, 61, 629-632.
173. Lawn, S. D., Butera, S. T., Incorporation of HLA-DR into the envelope of human immunodeficiency virus type 1 in vivo: correlation with stage of disease and presence of opportunistic infection. J. Virol. 2000, 74, 10256-10259.
174. Ott, D. E., Coren, L. V., Kane, B. P., Busch, L. K. et al., Cytoskeletal proteins inside human immunodeficiency virus type 1 virions. J. Virol. 1996, 70, 7734-7343.
175. Frank, I., Kacani, L., Stoiber, H., Stossel, H. et al., Human immunodeficiency virus type 1 derived from cocultures of immature dendritic cells with autologous T cells carries T-cell-specific molecules on its surface and is highly infectious. J. Virol. 1999, 73, 3449-3454.
176. Esser, M. T., Graham, D. R., Coren, L. V., Trubey, C. M. et al., Differential incorporation of CD45, CD80 (B7-1), CD86 (B7-2), and major histocompatibility complex class I and II molecules into human immunodeficiency virus type 1 virions and microvesicles: implications for viral pathogenesis and immune regulation. J. Virol. 2001, 75, 6173-6182.
177. Bounou, S., Dumais, N., Tremblay, M. J., Attachment of human immunodeficiency virus-1 (HIV-1) particles bearing host-encoded B7-2 proteins leads to nuclear factor-kappa B- and nuclear factor of activated T cells-dependent activation of HIV-1 long terminal repeat transcription. J. Biol. Chem. 2001, 276, 6359-6369.
178. Giguère, J. F., Paquette, J. S., Bounou, S., Cantin, R., Tremblay,
179. Roberts, B. D., Butera, S. T., Host protein incorporation is conserved among diverse HIV-1 subtypes. AIDS 1999, 13, 425-427.
180. Lawn, S. D., Roberts, B. D., Griffin, G. E., Folks, T. M., Butera, S. T., Cellular compartments of human immunodeficiency virus type 1 replication in vivo: determination by presence of virion-associated host proteins and impact of opportunistic infection. J. Virol. 2000, 74, 139-145.
181. Misumi, S., Fuchigami, T., Takamune, N., Takahashi, I. et al., Three isoforms of cyclophilin A associated with human immunodeficiency virus type 1 were found by proteomics by using two-dimensional gel electrophoresis and matrix-assisted laser desorption ionization-time of flight mass spectrometry. J. Virol. 2002, 76, 10000-10008.
182. Guo, M. M., Hildreth, J. E., HIV acquires functional adhesion receptors from host cells. AIDS Res. Hum. Retrovir. 1995, 11, 1007-1013.
183. Saifuddin, M., Parker, C. J., Peeples, M. E. et al., Role of virion-associated glycosylphosphatidylinositol-linked proteins CD55 and CD59 in complement resistance of cell line-derived and primary isolates of HIV-1. J. Exp. Med. 1995, 182, 501-509.
184. Saifuddin, M., Hedayati, T., Atkinson, J. P., Holguin, M. H. et al., Human immunodeficiency virus type 1 incorporates both glycosyl phosphatidylinositol-anchored CD55 and CD59 and integral membrane CD46 at levels that protect from complement-mediated destruction. J. Gen. Virol. 1997, 78, 1907-1911.
185. Bastiani, L., Laal, S., Kim, M., Zolla-Pazner, S., Host cell-dependent alterations in envelope components of human immunodeficiency virus type 1 virions. J. Virol. 1997, 71, 3444-3450.
186. Hildreth, J. E., Orentas, R. J., Involvement of a leukocyte adhesion receptor (LFA-1) in HIV-induced syncytium formation. Science 1989, 244, 1075-1078.
187. Bounou, S., Leclerc, J. E., Tremblay, M. J., Presence of host ICAM-1 in laboratory and clinical strains of human immunodeficiency virus type 1 increases virus infectivity and CD4(+)-T-cell depletion in human lymphoid tissue, a major site of replication in vivo. J. Virol. 2002, 76, 1004-14.
188. Rizzuto, C. D., Sodroski, J. G., Contribution of virion ICAM-1 to human immunodeficiency virus infectivity and sensitivity to neutralization. J. Virol. 1997, 71, 4847-4851.
189. Castilletti, C., Capobianchi, M. R., Fais, S. Gentile M. et al., HIV type 1 grown on interferon gamma-treated U937 cells shows selective increase in virion-associated intercellular adhesion molecule 1 and HLA-DR and enhanced infectivity for CD4-negative cells. AIDS Res. Hum. Retrovir. 1995, 11, 547-553.
190. Cantin, R., Fortin, J.F., Lamontagne, G., Tremblay, M., The acquisition of host-derived major histocompatibility complex class II glycoproteins by human immunodeficiency virus type 1 accelerates the process of virus entry and infection in human T-lymphoid cells. Blood 1997, 90, 1091-1100.
191. Cantin, R., Fortin, J. F., Lamontagne, G., Tremblay, M., The presence of host-derived HLA-DRI on human immunodeficiency virus type 1 increases viral infectivity. J. Virol. 1997, 71, 1922-1930.
192. Fortin, J. F., Cantin, R., Lamontagne, G., Tremblay, M., Host-derived ICAM-1 glycoproteins incorporated on human immunodeficiency virus type 1 are biologically active and enhance viral infectivity. J. Virol. 1997, 71, 3588-3596.
193. Cantin, R., Martin, G., Tremblay, M. J., A novel virus capture assay reveals a differential acquisition of host HLA-DR by clinical isolates of human immunodeficiency virus type 1 expanded in primary human cells depending on the nature of producing cells and the donor source. J. Gen. Virol. 2001, 82, 2979-2987.
194. Wasinger, V. C., Cordwell, S. J., Cerpa-Poljak, A., Yan, J. X. et al., Progress with gene-product mapping of the Mollicutes: Mycoplasma genitalium. Electrophoresis 1995, 16, 1090-1094.
195. Anderson, L., Seilhamer, J., A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 1997, 18, 533-537.
196. Person, A., Beaud, G., Shut-off of host protein synthesis in vaccinia-virus-infected cells exposed to cordycepin. A study in vitro. Eur. J. Biochem. 1980, 103, 85-93.
197. Ewing, R. M., Chu, P., Elisma, F., Li, H. et al., Large-scale mapping of human protein-protein interactions by mass spectrometry. Mol. Syst. Biol. 2007, 3, 89.
198. Tyers, M., Mann, M., From genomics to proteomics. Nature 2003, 13, 422, 193-197.
199. Severin, A., Nickbarg, E., Wooters, J., Quazi, S. A. et al., Proteomic analysis and identification of Streptococcus pyogenes surface-associated proteins. J. Bacteriol. 2007, 189, 1514-1522.
200. Nandakumar, R., Nandakumar, M. P., Marten, M. R., Ross, J. M., Proteome analysis of membrane and cell wall associated proteins from Staphylococcus aureus. J. Proteome Res. 2005, 4, 250-257.
201. Sellman, B. R., Howell, A. P., Kelly-Boyd, C., Baker, S. M., Identification of immunogenic and serum binding proteins of Staphylococcus epidermidis. Infect. Immun. 2005, 73, 6591-6600.
202. Cole, J. N., Ramirez, R. D., Currie, B. J., Cordwell, S. J. et al., Surface analyses and immune reactivities of major cell wall-associated proteins of group a streptococcus. Infect. Immun. 2005, 73, 3137-3146.
203. Hughes, M. J., Moore, J. C., Lane, J. D., Wilson, R. et al., Identification of major outer surface proteins of Streptococcus agalactiae. Infect. Immun. 2002, 70, 1254-1259.
204. Ling, E., Feldman, G., Portnoi, M., Dagan, R. et al., Glycolytic enzymes associated with the cell surface of Streptococcus pneumoniae are antigenic in humans and elicit protective immune responses in the mouse. Clin. Exp. Immunol. 2004, 138, 290-298.
205. Wright, A., Wait, R., Begum, S., Crossett, B. et al., Proteomic analysis of cell surface proteins from Clostridium difficile. Proteomics 2005, 5, 2443-2452.